参芪降糖颗粒由人参（茎叶）皂苷、黄芪等11味中药组成，具有降糖、抗炎、保护微血管等多种药理活性。因参芪降糖颗粒具有协同降糖，改善糖尿病患者症状和体征，提高生活质量的作用，《中国2型糖尿病防治指南（2020年版）》推荐其应用于糖尿病防治。对参芪降糖颗粒的药理作用及临床应用等进行总结，基于糖脂代谢病创新理论提出对参芪降糖颗粒防治疾病的认识，以期为参芪降糖颗粒的深入研究与临床推广提供科学支持。

Shenqi Jiangtang Granules (参芪降糖颗粒) is composed of eleven kinds of traditional Chinese medicines including total ginsenosides of Panax ginseng stems and leaves and Huangqi (Astragali Radix), etc. It has a variety of pharmacological effects, including hypoglycemic effects, anti-inflammation, and microvasculature protection and so on. Shenqi Jiangtang Granules has the effects of synergistically lowering glucose, improving the symptoms and signs of diabetic patients, and improving the quality of life. Therefore, Shenqi Jiangtang Granules is recommended by "Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 edition)" for application in the prevention and treatment of diabetes. The pharmacological action and clinical application of Shenqi Jiangtang Granules were summarized in this paper, and the understanding of prevention and treatment of Shenqi Jiangtang Granules was put forward based on the innovative theory of glycolipid metabolic disorders, in order to provide scientific support for further research and clinical practice.

R286.7

国家重点研发计划项目（2018YFC1704200）；国家重点研发计划项目（2018YFC1704205）；广东省基础与应用基础研究重大项目（2019B030302005）